Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains.
Crimean Congo hemorrhagic fever virus (CCHFV) is a deadly human pathogen that evades innate immune responses by efficiently interfering with antiviral signaling pathways mediated by NF-κB, IRF3, and IFNα/β. These pathways rely on protein ubiquitination for their activation, and one outcome is the modification of proteins with the ubiquitin (Ub)-like modifier interferon-stimulated gene (ISG)15. CCHFV and related viruses encode a deubiquitinase (DUB) of the ovarian tumor (OTU) family, which unlike eukaryotic OTU DUBs also targets ISG15 modifications. Here we characterized the viral OTU domain of CCHFV (vOTU) biochemically and structurally, revealing that it hydrolyzes four out of six tested Ub linkages, but lacks activity against linear and K29-linked Ub chains. vOTU cleaved Ub and ISG15 with similar kinetics, and we were able to understand vOTU cross-reactivity at the molecular level from crystal structures of vOTU in complex with Ub and ISG15. An N-terminal extension in vOTU not present in eukaryotic OTU binds to the hydrophobic Ile44 patch of Ub, which results in a dramatically different Ub orientation compared to a eukaryotic OTU-Ub complex. The C-terminal Ub-like fold of ISG15 (ISG15-C) adopts an equivalent binding orientation. Interestingly, ISG15-C contains an additional second hydrophobic surface that is specifically contacted by vOTU. These subtle differences in Ub/ISG15 binding allowed the design of vOTU variants specific for either Ub or ISG15, which will be useful tools to understand the relative contribution of ubiquitination vs. ISGylation in viral infection. Furthermore, the crystal structures will allow structure-based design of antiviral agents targeting this enzyme.
Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom.
Masato
M
Akutsu
Yu
Y
Ye
Satpal
S
Virdee
Jason W
JW
Chin
David
D
Komander
D016207:Cytokines / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D005260:Female; D003225:Hemorrhagic Fever Virus, Crimean-Congo / Q000201:enzymology / Q000235:genetics / Q000276:immunology*; D006801:Humans; D010051:Ovarian Neoplasms; D010447:Peptide Hydrolases / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D020836:Protein Structure, Quaternary; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D013329:Structure-Activity Relationship; D025801:Ubiquitin / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D054875:Ubiquitination / Q000276:immunology*; D014452:Ubiquitins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism
D016207:Cytokines; D025801:Ubiquitin; D014452:Ubiquitins; D014764:Viral Proteins; C074034:ISG15 protein, human; D010447:Peptide Hydrolases
Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):395-404
19027345
Nat Chem Biol. 2010 Oct;6(10):750-7
20802491
Cell. 2010 Oct 15;143(2):187-90
20946978
J Virol. 2010 Jan;84(1):216-26
19864393
Cell Host Microbe. 2007 Dec 13;2(6):404-16
18078692
Chem Biol. 2002 Oct;9(10):1149-59
12401499
Science. 2007 Dec 7;318(5856):1628-32
17991829
Nat Struct Mol Biol. 2010 Aug;17(8):939-47
20622874
Arch Biochem Biophys. 2007 Oct 1;466(1):8-14
17692280
Biochem J. 2009 Mar 1;418(2):379-90
18954305
Nat Cell Biol. 2009 May;11(5):527-34
19404332
Nat Cell Biol. 2009 Feb;11(2):123-32
19136968
J Biol Chem. 2005 Jul 22;280(29):27356-65
15917233
Front Biosci. 2005 Sep 01;10:2701-22
15970528
Biochem Soc Trans. 2009 Oct;37(Pt 5):937-53
19754430
J Biol Chem. 2008 Apr 18;283(16):11038-49
18270205
Annu Rev Biochem. 2009;78:769-96
19489733
Nat Rev Immunol. 2008 Jul;8(7):559-68
18575461
J Gen Virol. 2000 Apr;81(Pt 4):853-79
10725411
Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63
19626045
J Biol Chem. 2002 Mar 22;277(12):9976-81
11788588
Nature. 2009 Sep 3;461(7260):114-9
19675569
Curr Biol. 2010 Apr 13;20(7):R328-33
20392426
Nature. 2004 Aug 5;430(7000):694-9
15258597
Cell. 2010 Apr 16;141(2):315-30
20403326
Mol Cell. 2010 Jun 11;38(5):722-32
20542004
Cell. 2006 Feb 24;124(4):783-801
16497588
EMBO Rep. 2009 May;10(5):466-73
19373254